143268-79-5

Basic information

• Product Name: 8-FLUORO-3,4-DIHYDRO-1H QUINOLIN-2-ONE
• Synonyms: 8-FLUORO-3,4-DIHYDRO-1H QUINOLIN-2-ONE;8-Fluoro-3,4-dihydroquinolin-2(1H)-one;8-Fluoro-3,4-dihydroquinolin-2(1H)
• CAS NO: 143268-79-5
• Molecular Formula: C9H8FNO
• Molecular Weight: 165.1643232
• Mol File: 143268-79-5.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 315.138 °C at 760 mmHg
• Flash Point: 144.39 °C
• Appearance: /
• Density: 1.242 g/cm³
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 8-FLUORO-3,4-DIHYDRO-1H QUINOLIN-2-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 8-FLUORO-3,4-DIHYDRO-1H QUINOLIN-2-ONE(143268-79-5)
• EPA Substance Registry System: 8-FLUORO-3,4-DIHYDRO-1H QUINOLIN-2-ONE(143268-79-5)

Safety Data

• Hazardous Substances Data: 143268-79-5(Hazardous Substances Data)

Usage

General Description

8-Fluoro-3,4-dihydro-1H quinolin-2-one is a chemical compound with the molecular formula C9H7NOF. It is a synthetic compound that may have pharmaceutical or research applications. The structure of the compound includes a quinolin-2-one core with a fluorine atom at the 8 position and a dihydro group at the 3 and 4 positions. 8-FLUORO-3,4-DIHYDRO-1H QUINOLIN-2-ONE may have potential biological activity due to its structural similarities to other quinolinone compounds, but further research and testing would be needed to determine its specific properties and potential uses.

Upstream product

• 348-54-9 2-Fluoroaniline 
• 349097-66-1 3-chloro-N-(2-fluoro-phenyl)-propionamide 

Downstream Products

• 1404367-02-7 9-fluoro-1-methyl-7-(5-phenyl-pyridin-3-yl)-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline 

Relevant articles and documents

Novel pyridyl substituted 4,5-dihydro-[1,2,4]triazolo[4,3-a ]quinolines as potent and selective aldosterone synthase inhibitors with improved in vitro metabolic stability

CYP11B2 inhibition is a promising treatment for diseases caused by excessive aldosterone. To improve the metabolic stability in human liver miscrosomes of previously reported CYP11B2 inhibitors, modifications were performed via a combination of ligand-and

NEW BICYCLIC DIHYDROQUINOLINE-2-ONE DERIVATIVES

The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12/

NEW BICYCLIC DIHYDROQUINOLINE-2-ONE DERIVATIVES

The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4? R5, R6, R7, R8, R9, R10, R11, R12/